EBV-specific cytotoxic T lymphocytes (EBV-CTL therapy)

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-specific cytotoxic T lymphocytes (EBV-CTL therapy), covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL [Phase 1]

See pricing